Published in Ann N Y Acad Sci on December 01, 2004
[Pt(O,O'-acac)(γ-acac)(DMS)] alters SH-SY5Y cell migration and invasion by the inhibition of Na+/H+ exchanger isoform 1 occurring through a PKC-ε/ERK/mTOR Pathway. PLoS One (2014) 1.49
Chemical Tumor Biology of Heparan Sulfate Proteoglycans. Curr Chem Biol (2010) 1.17
Malignant progression and blockade of angiogenesis in a murine transgenic model of neuroblastoma. Cancer Res (2007) 1.11
Stromal cell-derived CSF-1 blockade prolongs xenograft survival of CSF-1-negative neuroblastoma. Int J Cancer (2010) 1.03
The connections between neural crest development and neuroblastoma. Curr Top Dev Biol (2011) 1.01
Targeting angiogenesis for controlling neuroblastoma. J Oncol (2011) 0.95
Erythropoietin/erythropoietin receptor system is involved in angiogenesis in human neuroblastoma. Histopathology (2007) 0.91
Chemokine receptor CXCR4 as a therapeutic target for neuroectodermal tumors. Semin Cancer Biol (2008) 0.90
MYCN-mediated transcriptional repression in neuroblastoma: the other side of the coin. Front Oncol (2013) 0.89
Ets1 transcription factor mediates gastrin-releasing peptide-induced IL-8 regulation in neuroblastoma cells. Neoplasia (2007) 0.82
Angiogenesis in a human neuroblastoma xenograft model: mechanisms and inhibition by tumour-derived interferon-gamma. Br J Cancer (2006) 0.82
ALK(R1275Q) perturbs extracellular matrix, enhances cell invasion and leads to the development of neuroblastoma in cooperation with MYCN. Oncogene (2016) 0.77
Calreticulin Regulates VEGF-A in Neuroblastoma Cells. Mol Neurobiol (2014) 0.76
Inhibition of the SK-N-MC human neuroblastoma cell line in vivo and in vitro by a novel nutrient mixture. Oncol Rep (2013) 0.76
Vascular endothelial growth factor in children with neuroblastoma: a retrospective analysis. J Exp Clin Cancer Res (2009) 0.76
SPARC overexpression combined with radiation retards angiogenesis by suppressing VEGF-A via miR‑410 in human neuroblastoma cells. Int J Oncol (2016) 0.75
Walker 256 Tumor Growth Suppression by Crotoxin Involves Formyl Peptide Receptors and Lipoxin A4. Mediators Inflamm (2016) 0.75
Intra-adrenal murine TH-MYCN neuroblastoma tumors grow more aggressive and exhibit a distinct tumor microenvironment relative to their subcutaneous equivalents. Cancer Immunol Immunother (2015) 0.75
Bcr-Abl stabilizes beta-catenin in chronic myeloid leukemia through its tyrosine phosphorylation. EMBO J (2007) 2.11
Spot overlapping in two-dimensional maps: a serious problem ignored for much too long. Proteomics (2005) 1.79
The gelatin sponge-chorioallantoic membrane assay. Nat Protoc (2006) 1.77
Bortezomib mediates antiangiogenesis in multiple myeloma via direct and indirect effects on endothelial cells. Cancer Res (2006) 1.72
Alpha(v)beta(3) integrin engagement enhances cell invasiveness in human multiple myeloma. Haematologica (2002) 1.69
Neovascularization and mast cells with tryptase activity increase simultaneously with pathologic progression in human endometrial cancer. Am J Obstet Gynecol (2005) 1.69
Phase I trial and pharmacokinetics of fenretinide in children with neuroblastoma. Clin Cancer Res (2003) 1.50
Markers of increased angiogenesis and their correlation with biological parameters identifying high-risk patients in early B-cell chronic lymphocytic leukemia. Leuk Res (2007) 1.48
Salvage therapy with thalidomide in patients with advanced relapsed/refractory multiple myeloma. Haematologica (2002) 1.47
Vascular damage and anti-angiogenic effects of tumor vessel-targeted liposomal chemotherapy. Cancer Res (2003) 1.45
The role of pericytes in angiogenesis. Int J Dev Biol (2011) 1.42
Angiogenesis in acute and chronic lymphocytic leukemia. Leuk Res (2004) 1.41
Targeting liposomal chemotherapy via both tumor cell-specific and tumor vasculature-specific ligands potentiates therapeutic efficacy. Cancer Res (2006) 1.37
Endothelial cell heterogeneity and organ specificity. J Hematother Stem Cell Res (2002) 1.35
A new image analysis method based on topological and fractal parameters to evaluate the angiostatic activity of docetaxel by using the Matrigel assay in vitro. Microvasc Res (2004) 1.35
Macrophages are alternatively activated in patients with endometriosis and required for growth and vascularization of lesions in a mouse model of disease. Am J Pathol (2009) 1.33
Effect of bortezomib on human neuroblastoma cell growth, apoptosis, and angiogenesis. J Natl Cancer Inst (2006) 1.32
MHC class I antigen processing and presenting machinery: organization, function, and defects in tumor cells. J Natl Cancer Inst (2013) 1.31
Evaluation of microvascular density in tumors: pro and contra. Histol Histopathol (2008) 1.30
Extra-articular manifestations of rheumatoid arthritis: An update. Autoimmun Rev (2011) 1.24
Lymphatics at the crossroads of angiogenesis and lymphangiogenesis. J Anat (2004) 1.22
Targeted drug delivery and penetration into solid tumors. Med Res Rev (2011) 1.19
Docetaxel versus paclitaxel for antiangiogenesis. J Hematother Stem Cell Res (2002) 1.16
Aquaporins in skeletal muscle: reassessment of the functional role of aquaporin-4. FASEB J (2004) 1.16
Gene expression profiling of bone marrow endothelial cells in patients with multiple myeloma. Clin Cancer Res (2009) 1.16
Endothelial cells in the bone marrow of patients with multiple myeloma. Blood (2003) 1.15
Dasatinib: an anti-tumour agent via Src inhibition. Curr Drug Targets (2011) 1.15
Enhanced antitumor efficacy of clinical-grade vasculature-targeted liposomal doxorubicin. Clin Cancer Res (2008) 1.14
Tumor vascular targeting with tumor necrosis factor alpha and chemotherapeutic drugs. Ann N Y Acad Sci (2004) 1.14
Lenalidomide restrains motility and overangiogenic potential of bone marrow endothelial cells in patients with active multiple myeloma. Clin Cancer Res (2011) 1.12
Doxorubicin-loaded Fab' fragments of anti-disialoganglioside immunoliposomes selectively inhibit the growth and dissemination of human neuroblastoma in nude mice. Cancer Res (2003) 1.12
Angiogenesis and anti-angiogenesis in hepatocellular carcinoma. Cancer Treat Rev (2006) 1.10
A multidisciplinary evaluation of the effectiveness of cyclosporine a in dystrophic mdx mice. Am J Pathol (2005) 1.10
Piecemeal degranulation as a general secretory mechanism? Anat Rec A Discov Mol Cell Evol Biol (2003) 1.09
Mast cells and angiogenesis in gastric carcinoma. Int J Exp Pathol (2010) 1.09
The ImmunoCAP ISAC molecular allergology approach in adult multi-sensitized Italian patients with respiratory symptoms. Clin Biochem (2011) 1.08
Development of a real-time polymerase chain reaction assay for prediction of the uptake of meta-[(131)I]iodobenzylguanidine by neuroblastoma tumors. Clin Cancer Res (2003) 1.08
In vivo activation of JAK2/STAT-3 pathway during angiogenesis induced by GM-CSF. FASEB J (2001) 1.06
Thalidomide downregulates angiogenic genes in bone marrow endothelial cells of patients with active multiple myeloma. J Clin Oncol (2005) 1.05
Combined therapeutic effects of vinblastine and rapamycin on human neuroblastoma growth, apoptosis, and angiogenesis. Clin Cancer Res (2007) 1.05
Critical role of flanking residues in NGR-to-isoDGR transition and CD13/integrin receptor switching. J Biol Chem (2010) 1.05
Bone marrow endothelial cells in multiple myeloma secrete CXC-chemokines that mediate interactions with plasma cells. Br J Haematol (2005) 1.04
Mast cells and tumour angiogenesis: new insight from experimental carcinogenesis. Cancer Lett (2008) 1.04
Gentamicin treatment in exercised mdx mice: Identification of dystrophin-sensitive pathways and evaluation of efficacy in work-loaded dystrophic muscle. Neurobiol Dis (2008) 1.03
The discovery of basic fibroblast growth factor/fibroblast growth factor-2 and its role in haematological malignancies. Cytokine Growth Factor Rev (2007) 1.02
Salvage treatment with lenalidomide and dexamethasone in relapsed/refractory mantle cell lymphoma: clinical results and effects on microenvironment and neo-angiogenic biomarkers. Haematologica (2011) 1.02
Expression and methylation of CASP8 in neuroblastoma: identification of a promoter region. Nat Med (2002) 1.02
Morphological and molecular aspects of physiological vascular morphogenesis. Angiogenesis (2009) 1.02
The role of adrenomedullin in angiogenesis. Peptides (2005) 1.02
Oct-4+/Tenascin C+ neuroblastoma cells serve as progenitors of tumor-derived endothelial cells. Cell Res (2011) 1.02
Cancer-related coagulopathy (Trousseau's syndrome): review of the literature and experience of a single center of internal medicine. Clin Exp Med (2013) 1.01
Mechanisms of free-radical induction in relation to fenretinide-induced apoptosis of neuroblastoma. J Cell Biochem (2003) 1.01
Osteopontin (Eta-1) and fibroblast growth factor-2 cross-talk in angiogenesis. J Immunol (2003) 1.00
Bcl-2 overexpression in melanoma cells increases tumor progression-associated properties and in vivo tumor growth. J Cell Physiol (2005) 1.00
Role of mitochondria and reactive oxygen species in dendritic cell differentiation and functions. Free Radic Biol Med (2008) 1.00
Neovascularization and mast cells with tryptase activity increase simultaneously in human pterygium. J Cell Mol Med (2007) 0.99
Novel strategies in the treatment of castration-resistant prostate cancer (Review). Int J Oncol (2012) 0.98
Endothelial progenitor cells in sudden sensorineural hearing loss. Acta Otolaryngol (2010) 0.98
The role of microenvironment in tumor angiogenesis. Genes Nutr (2008) 0.98
Targeted liposomal c-myc antisense oligodeoxynucleotides induce apoptosis and inhibit tumor growth and metastases in human melanoma models. Clin Cancer Res (2003) 0.98
Tryptase and chymase are angiogenic in vivo in the chorioallantoic membrane assay. Int J Dev Biol (2011) 0.98
Antiproliferative and pro-apoptotic activity of eugenol-related biphenyls on malignant melanoma cells. Mol Cancer (2007) 0.98
Mast cells contribute to vasculogenic mimicry in multiple myeloma. Stem Cells Dev (2008) 0.98
Soluble intercellular adhesion molecule 1 and soluble vascular cell adhesion molecule 1 in sudden hearing loss. Otol Neurotol (2008) 0.97
Resveratrol exerts antiproliferative activity and induces apoptosis in Waldenström's macroglobulinemia. Clin Cancer Res (2008) 0.97
Leptin-leptin receptor are involved in angiogenesis in human hepatocellular carcinoma. Peptides (2008) 0.97
Frizzled receptor 6 marks rare, highly tumourigenic stem-like cells in mouse and human neuroblastomas. Oncotarget (2011) 0.97
Enalapril treatment discloses an early role of angiotensin II in inflammation- and oxidative stress-related muscle damage in dystrophic mdx mice. Pharmacol Res (2011) 0.96